Literature DB >> 26209711

Response.

Chun Chieh Lin1, Phillip J Gray1, Ahmedin Jemal1, Jason A Efstathiou2.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 26209711      PMCID： PMC4836805          DOI： 10.1093/jnci/djv201

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  6 in total

1.  The impact of definitive local therapy for lymph node-positive prostate cancer: a population-based study.

Authors:  Chad G Rusthoven; Julie A Carlson; Timothy V Waxweiler; David Raben; Peter E Dewitt; E David Crawford; Paul D Maroni; Brian D Kavanagh
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-01       Impact factor: 7.038

2.  Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results.

Authors:  Siamak Daneshmand; Marcus L Quek; John P Stein; Gary Lieskovsky; Jie Cai; Jacek Pinski; Eila C Skinner; Donald G Skinner
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

Review 3.  Pelvic lymph node dissection in prostate cancer.

Authors:  Alberto Briganti; Michael L Blute; James H Eastham; Markus Graefen; Axel Heidenreich; Jeffrey R Karnes; Francesco Montorsi; Urs E Studer
Journal:  Eur Urol       Date:  2009-03-10       Impact factor: 20.096

4.  Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.

Authors:  Alberto Briganti; Jeffrey R Karnes; Luigi Filippo Da Pozzo; Cesare Cozzarini; Andrea Gallina; Nazareno Suardi; Marco Bianchi; Massimo Freschi; Claudio Doglioni; Ferruccio Fazio; Patrizio Rigatti; Francesco Montorsi; Michael L Blute
Journal:  Eur Urol       Date:  2008-10-01       Impact factor: 20.096

5.  Impact of adjuvant radiotherapy on survival of patients with node-positive prostate cancer.

Authors:  Firas Abdollah; R Jeffrey Karnes; Nazareno Suardi; Cesare Cozzarini; Giorgio Gandaglia; Nicola Fossati; Damiano Vizziello; Maxine Sun; Pierre I Karakiewicz; Mani Menon; Francesco Montorsi; Alberto Briganti
Journal:  J Clin Oncol       Date:  2014-09-22       Impact factor: 44.544

6.  Long-term outcome after radical prostatectomy for patients with lymph node positive prostate cancer in the prostate specific antigen era.

Authors:  Stephen A Boorjian; R Houston Thompson; Sameer Siddiqui; Stephanie Bagniewski; Erik J Bergstralh; R Jeffrey Karnes; Igor Frank; Michael L Blute
Journal:  J Urol       Date:  2007-07-16       Impact factor: 7.450
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.